ABSTRACT
Inversion of chromosome 16 [inv(16)(p13.1q22)] and t(16;16)(p13.1;q22) are associated with acute myelomonocytic leukemia (AMML) with eosinophilia and a favorable prognosis. On the other hand, patients with del(16)(q22) usually present with MDS or chronic myelomonocytic leukemia (CMML), which can evolve to AMML without eosinophilia, and this chromosomal aberration is associated with older age, a complex karyotype, and a poor prognosis. We report a case of AML with del(16)(q22) which showed a complex karyotype, absence of eosinophilia in bone marrow study and a poor response to chemotherapy.
Subject(s)
Humans , Male , Middle Aged , Antimetabolites, Antineoplastic/therapeutic use , Chromosome Deletion , Chromosomes, Human, Pair 16 , Cytarabine/therapeutic use , Daunorubicin/therapeutic use , Drug Therapy, Combination , In Situ Hybridization, Fluorescence , Karyotyping , Leukemia, Myeloid, Acute/diagnosis , Monocyte-Macrophage Precursor Cells/cytology , PrognosisABSTRACT
Deletion of the long arm of chromosome 16 is uncommon. The causes of deletion are two: one is unbalanced translocation and the other is de novo deletion. In our case, a baby was born with characteristics of the deletion of the long arm of chromosome 16: distinct craniofacial dysmorphism, mild hydrocephalus, ventriculoseptal defect, coarctation of aorta, short neck, low set, small and posterially rotated ears and shortening of long bones. High resolution GTG and RBG banding analyses revealed a karyotype: 46, XY, del(16)(q13q22) de novo.